Summary. Subcutaneous injection of fimbriae from Porphyromonas gingivalis strain 38 1 in Freund's incomplete adjuvant (FIA) resulted in an excellent serum anti-fimbrial immunoglobulin G (IgG) response in guinea-pigs and BALB/c mice. Administration of P. gingivalis fimbriae also elicited distinct cellular immune responses to the fimbriae in terms of ear lobe reaction in BALB/c but not in BALB/c nu/nu mice, and of skin reaction in guineapigs. When the guinea-pigs were given a semi-synthetic adjuvant GM-53-sodium
Introduction
Porphyromonas gingivalis is a gram-negative, blackpigmented anaerobic bacterium that has been associated with the development of chronic periodontal diseases in man.l Antigen-specific antibodies to the surface components of P. gingivalis have been detected in the serum and crevicular fluid of patients with periodontal Among these components, the fimbriae of P. gingivalis have been presumed to be important for the adherence of the organisms to host
We have shown previously that P. gingivalis fimbria-specific antibody-secreting cells are increased in the inflamed gingival tissues of patients with periodontal diseases, and antigen-specific antibodies are present in their serum.9 It has been shown also that subcutaneous or oral immunisation with P. gingivalis fimbriae in BALB/c mice induces markedly increased levels of fimbria-specific IgA or IgG antibodies, or both, in saliva and serum, and fimbria-specific antibody-producing cells have been detected in various lymphoid tissues. lO functional properties such as antigenicity, haemagglutinating activity, mitogenic and polyclonal B-cell activation (PBA) activity for mouse splenocytes and induction of production of cytokines such as tumour necrosis factor-alpha (TNF-a) and interleukin-6 (IL-6) in human monocyte/macrophage cultures.12 The present study was designed to determine if P. gingivalis fimbriae and their synthetic peptide segments known to exert various immunobiological effects in a host would induce humoral and cellular immune responses and exhibit immuno-adjuvanticity in guinea-pigs and mice.
Materials and methods

Animals
Male BALB/c and BALB/c nu/nu mice (8 weeks old) were obtained from Japan SLC, Inc., Hamamatsu, Japan. Closed-colony male albino guinea-pigs (weight 300-350 g) were purchased from Nihon Rabbit Inc., Osaka, Japan.
Preparation of Jimbriae from P. gingivalis 381
P. gingivalis strain 38 1 was grown anaerobically in GAM broth (Nissui, Tokyo, Japan) supplemented with haemin and menadione for 26 h at 37"C, and its fimbriae were isolated as described previously." No contaminating proteins were detected by SDS-PAGE, and the subunit structure of fimbriae, fimbrilin, was identified as a single band of the 41-kDa subunit protein. lo 
Synthesis of peptide
Peptides FP38 l(6 1-80), whose amino-acid sequence is GKTLAEVKALTTELTAENQE, and FP38 l(202-221), which corresponds to VAPAADAPQGFTVL-ENDYSA, based on the amino-acid sequence of the native fimbrilin of P. gingivalis 381 derived from the nucleotide sequence,13 were synthesised with a model 9050 peptide synthesiser (Japan Millipore Ltd, Tokyo) by the solid-phase methods.l* After cleavage of the protecting groups with trifluoroacetic acid : m-cresol : ethanedithiol : methanesulphonic acid (90 : 2-5 : 5 : 2.5), the peptide was purified by high performance liquid chromatography on a reversed phase column (Capcell Pak C18 SG120, 1.5 x 15 cm; Shiseido, Tokyo) with a linear gradient (660%) of acetonitrile in acetic acid 0.1 % at a flow rate of 23 ml/min. The major peak fraction of the peptide was collected by monitoring the absorbance at 2201x11. The purified peptide synthesised was analysed for composition by quantitative amino-acid analysis and sequenced by automated Edman degradation with a model 6400/6600 protein sequencer (Japan Millipore Ltd).
Adjuvant
Muramyldipeptide (MDP) and sodium P-N-acetylglucosaminyl-( 1 + 4)-N-acetylmuramyl-~-alanyl-~-isoglutaminyl-(~)-stearoyl-(~)-meso-2, 6-diaminopimelic acid-(D)-amide-D-alanine (GM-53)15 were generously supplied by Daiichi Seiyaku Co., Tokyo and Dainippon Pharmaceutical Co., Osaka, respectively. Freund's incomplete adjuvant (FIA) was purchased from Difco.
Assay for humoral and cellular immuPze responses
Groups of six guinea-pigs were given various doses of fimbriae on their synthetic peptides by injection into the left hind footpad with or without a dose of adjuvant GM-53 in FIA on day 0. Skin tests were performed to evaluate the induction of a cellular immune response to fimbrial antigen or the synthetic peptide segments of the fimbriae.16 Briefly, the immunised guinea-pigs were given either an intracutaneous injection of 100 pg of fimbriae or of their synthetic peptide segments 35 days after immunisation. The skin test was examined for the extent and degree of redness, swelling and necrosis 48 h after the intradermal provocative injection. Serum specimens were taken 1 day after the skin test and stored at -80°C until assayed. The immunoglobulin G (IgG) levels of antigen-specific antibodies in the serum of the guinea-pigs were determined by an ELISA technique." The individual values are expressed as points and the bars indicate the median values.
In some experiments, groups of 10 BALB/c and BALB/c nu/nu mice were given 100 pg of the fimbriae in FIA by subcutaneous injection on days 0 and 28. On day 33 these mice were given 10 pg of the fimbriae by intracutaneous injection into the ear lobe, whose thickness at the injection site was measured daily for 3 days with a dial gauge (Model G ; Ozaki Corp., Tokyo). Serum specimens were taken 1 day after the ear lobe test. Antigen-specific IgG levels were determined by EL1SA.l'
Immuno-adjuvant activity in mice
BALB/c mice (1 O/group) were immunised by subcutaneous injection of 100 pg of bovine serum albumin (BSA; Sigma) with or without 100 pg of test specimen in PBS or FIA, or were given FIA alone, on days 0 and 28. Serum anti-BSA IgG antibody levels were determined by ELISA 5 days after the secondary immunisa tion.
Stat is tical analysis
The significance of differences between means of groups was determined by Student's t test.
Results
Induction of humoral and cellular immune responses in guinea-pigs and BALB/c mice after immunisation with P. gingivalis Jimbriae
Guinea-pigs immunised with P. gingivalis 381 fimbriae in FIA were found to have raised anti-fimbrial IgG antibody levels in their serum ( fig. 1 ). Subcutaneous injection of P. gingivalis fimbriae in FIA resulted in a dose-dependent induction of serum antibody responses over a concentration range of 50-500 pg of fimbriae/animal. The production of fimbria-specific IgG reached its maximum at 500pg and was reduced at 1000 pglanimal. Furthermore, the addition of a semi-synthetic adjuvant, GM-53, a stearoyl derivative of the disaccharide tetrapeptide isolated from Lactobacillus plantarum cell walls, resulted in much higher levels of fimbria-specific IgG responses in serum ( fig. 1) . The greatest adjuvant effect was observed when GM-53 was given subcutaneously to guinea-pigs at the maximum dosage of 50Opgl animal with an equal dose of fimbriae. On the other hand, whereas P. gingivalis fimbriae also induced antifimbrial IgG in serum after immunisation in BALB/c mice, the did not do so in BALB/c nu/nu mice (data not shown).
P. gingivalis fimbriae could induce a cellular immune response in guinea-pigs when administered subcutaneously with or without adjuvant GM-53 in FIA. Fig. 2 illustrates the skin reaction after intradermal challenge of guinea-pigs immunised with fimbriae with other hand, whereas P. gingivalis fimbriae induced or without GM-53 in FIA or FIA alone. A clear marked ear lobe reactions in BALB/c mice on intradifference in the redness and swelling of the skin was dermal challenge, they did not do so in BALB/c nu/nu noted between the immunised groups and the control mice ( fig. 3 ). group. P. gingivalis fimbriae were clearly found to induce a skin reaction in guinea-pigs and a linear doseInduction of humoral and cellular immune responses in reaction relationship was seen between the dose of guinea-pigs after imrnunisa t ion with syn the t ic pep t ide offimbrilin fimbriae and the degree of this skin reaction and presence of necrosis ( fig. 2) . In animals given fimbriae together with adjuvant GM-53 (500 pg) the swelling at Synthetic peptide segments FP38 l(61-80) and the challenge site was more severe than in animals FP381(202-221) were investigated for induction of given an equal dose of fimbriae alone ( fig. 2) . On the humoral and cellular immune responses in guinea- FIA. The adjuvant activity of MDP in PBS was significantly greater than that of the fimbriae (p < 0.0001) but fimbriae in FIA showed more adjuvancy than MDP in FIA (p < 0.005).
Discussion
P . gingivalis cell surface antigens have been found to exhibit strong immune responses in man and animals. Enhanced levels of antibodies specific for these anti- Recently, we have found that the number of P . gingivalis fimbriae-specific antibody producing cells were increased markedly in the gingival tissues of patients with advanced adult period on ti ti^.^ We have also reported that raised levels of anti-fimbrial antibodies in serum and saliva and increased numbers of antigen-specific antibody-producing cells in various tissues were observed in BALB/c mice immunised subcutaneously or orally with P. gingivalis fimbriae in FIA or l i p o s~m e s .~~~~~~'~ In this study, a cellular as well as a humoral immune response to P. gingivalis fimbriae occurred in guinea-pigs and BALB/c mice given the fimbriae with or without a semi-synthetic adjuvant GM-53 in FIA by subcutaneous injection.
Subcutaneous injection of P . gingivalis fimbriae together with FIA significantly raised the levels of anti-fimbrial IgG in serum and induced a marked ear lobe reaction to a provocative challenge in BALB/c but not in BALB/c nu/nu mice. However, administration of a protein antigen, BSA or ovalbumin (OA), did not result in a significant ear lobe reaction in BALB/c mice immunised with BSA or OA in FIA (data not shown). These results revealed that P . gingivalis fimbriae induce cellular as well as humoral immune responses, and we suggest that this antigenicity depends on the T cells of BALB/c mice.
Our previous studies indicated that chemically synthesised oligopeptide segments of the fimbrial subunit protein (fimbrilin) of P. gingivalis strain 381 exhibited a variety of immunobiological activities such as agglutination of rabbit erythrocytes, mitogenicity and PBA activities and induction of cytokines in human monocyte-macrophage cultures.12 From amongst these synthetic peptides we selected two peptide segments : FP38 l(202-221), which was one of the immunodominant epitopes of the fimbrial protein as shown by its inhibition of the ELISA reaction for rabbit IgG specific for P. gingivalis fimbriae, and FP38 l(6 1-80) that agglutinated rabbit erythrocytes, was mitogenic and caused PBA of BALB/c splenocytes. These peptides were found to induce cytokines such as TNF-a and IL-6 production in human monocyte-macrophage cultures.12 ELISA reaction revealed that levels of FP381(202-221)-but not FP38 1(61-80)-specific IgG were elevated in serum from guinea-pigs which had been immunised with P. gingivalis fimbriae (fig. 4) . Fimbriae also reacted with serum from guinea-pigs immunised with FP38 l(202-221). Furthermore, FP381(61-80) and FP381(202-22 1) were themselves antigenic for guinea-pigs. How-
